First-in-human Single Ascending Dose Study of LNA043 in Patients Scheduled for Total Knee Replacement
Clinical trial NCT02491281 · COMPLETED
Trial details
- NCT number
- NCT02491281
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-16
- Primary completion
- 2018-02-07
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.